Kenneth Reed
Net worth: 4 M $ as of 2026-05-30
Net worth: 4 M $ as of 2026-05-30
Kenneth Reed is the founder of Prescient Pharma LLC.
Current jobs include Director at Minerva Biotechnologies Corp.
and Independent Director at RedHill Biopharma Ltd. Education history includes an undergraduate degree from Brown University, a doctorate from the University of Medicine & Dentistry of New Jersey, and an undergraduate degree from Harvard Medical School.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-26 | 42,130,000 ( 0.08% ) | 4 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| REDHILL BIOPHARMA LTD. | Director/Board Member | 2009-12-14 |
Minerva Biotechnologies Corp.
Minerva Biotechnologies Corp. Medical DistributorsDistribution Services Provides medical services | Director/Board Member | 2011-02-20 |
| Companies | Position | End |
|---|---|---|
Prescient Pharma LLC | Founder | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Minerva Biotechnologies Corp.
Minerva Biotechnologies Corp. Medical DistributorsDistribution Services Provides medical services | Distribution Services |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Medicine & Dentistry of New Jersey
University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RedHill Biopharma Ltd.
RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services | Health Technology |
Prescient Pharma LLC |
Select your edition
All financial news and data tailored to specific country editions